Neurovascular Devices or Interventional Neurology Market Size, Share & Trends Analysis Report By Products, By End-User (Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes), By Region, And By Segment Forecasts, 2025-2034

Report Id: 1345 Pages: 170 Last Updated: 30 June 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Neurovascular Devices or Interventional Neurology Market Size is valued at 3.29 Billion in 2024 and is predicted to reach 7.70 Billion by the year 2034 at a 9.0 % CAGR during the forecast period for 2025-2034.

Neurovascular Devices or Interventional Neurology Market info

Neurovascular conditions encompass intracranial aneurysms, ischemic stroke, subarachnoid hemorrhage, cavernous malformations, arteriovenous malformations, carotid disease, intracerebral hemorrhage, and moyamoya disease. Neurovascular devices treat a blood vessel or blood flow that impairs brain and nervous system function.

Multiple factors drive the growth of the neurovascular devices or interventional neurology market, including the increasing prevalence of neurovascular diseases, the development of new neurovascular devices, improved medical reimbursement policies, rising demand for safe and effective neurovascular devices, a well-established healthcare infrastructure, and an increase in research and development activities for neurovascular therapies. Besides this, growing patient demand for minimally invasive treatments results in the innovation and launch of neurovascular devices, which is likely to drive the growth of the neurovascular devices market. For instance, in August 2020, Stryker Corporation (US) launched the Surpass Evolve Flow Diverter and received U.S. FDA approval for the same. This diverter is the first 64-wire cobalt-chromium flow diverter in the U.S. designed to re-direct blood flow and promote aneurysm healing. However, the elevated cost of neurovascular devices and treatments may restrain the market’s growth.

Market Segmentation

The neurovascular devices or interventional neurology market is classified based on the products, end-users, and region. The products segment is categorized into aneurysm coiling & embolization devices (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting systems (carotid artery stents, embolic protection, balloon catheters), support devices (microcatheters and guidewires), and neurothrombectomy devices (clot retrievals, suction & aspiration, snares). By end-users, the market is segmented into hospitals & surgical centres, ambulatory care centres, and research laboratories & academic institutes. The hospitals & surgical centres segment is estimated to proliferate in the coming years due to the rising surgical operations and better reimbursement policies for hospital-based interventions. Geographically, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America is projected to witness lucrative growth in this market during the forecast period due to the well-developed healthcare facilities and rising prevalence of stroke & chronic diseases in this region.

Competitive Landscape

Some Major Key Players In The Neurovascular Devices Or Interventional Neurology Market:

  • Johnson & Johnson
  • Medtronic PLC
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Kaneka Corp.
  • Integer Holdings Corporation
  • Balt
  • Perflow Medical
  • Phenox GmbH
  • Sensome
  • Evasc
  • Rapid Medical
  • Asahi Intecc Co. Ltd
  • Acandis GmbH
  • Medikit Co. Ltd
  • Imperative Care
  • Lepu Medical
  • Cerus Endovascular
  • MicroVention, Inc.
  • Mizuho Medical
  • Peter Lazic GmBH
  • Spartan Micro
  • Emboflu
  • Straub Medical AG
  • AngioDynamics
  • Microbot Medical Inc.

Neurovascular Devices or Interventional Neurology Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD 3.29 Billion
Revenue Forecast In 2034 USD 7.70 Billion
Growth Rate CAGR CAGR of 9.0% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Million and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered Products, End-User
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia
Competitive Landscape Johnson & Johnson (US), Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), Microport Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation (US), Balt (France), Perflow Medical (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (US), Lepu Medical (China), Cerus Endovascular (US), MicroVention, Inc. (US), Mizuho Medical (Japan), Peter Lazic GmBH (Germany), Spartan Micro (US), Emboflu (Switzerland), Straub Medical AG (Switzerland), AngioDynamics (US), Microbot Medical Inc. (US) and others. Companies Mentioned
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Segmentation Of Neurovascular Devices or Interventional Neurology Market

Global Neurovascular Devices or Interventional Neurology Market, by Products

  • Aneurysm Coiling & Embolization Devices
  • Embolic Coils
  • Bare Detachable Coils
  • Coated Detachable Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Balloon Catheters
  • Support Devices
  • Microcatheters
  • Guidewires
  • Neurothrombectomy devices
  • Clot Retrievals
  • Suction & Aspiration Devices
  • Snares

Neurovascular Devices or Interventional Neurology Market

Global Neurovascular Devices or Interventional Neurology Market, by End-Users

  • Hospitals & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes

Global Neurovascular Devices or Interventional Neurology Market, by Region,

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Neurovascular Devices or Interventional Neurology Market, by Country

  • U.S.
  • Canada

Europe Neurovascular Devices or Interventional Neurology Market, by Country,

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Neurovascular Devices or Interventional Neurology Market, by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Neurovascular Devices or Interventional Neurology Market, by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Neurovascular Devices or Interventional Neurology Market, by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5314
Security Code field cannot be blank!

Frequently Asked Questions

Asahi Intecc Co. Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (US), Lepu Medical (China), Cerus Endovascular (US), O

Neurovascular Devices or Interventional Neurology Market Size is valued at 3.29 Billion in 2024 and is predicted to reach 7.70 Billion by the year 203

The Neurovascular Devices or Interventional Neurology Market is expected to grow at a 9.0% CAGR during the forecast period for 2025-2034.

Neurovascular devices or interventional neurology market is classified based on the products, end-users, and region.

North America region is leading the Neurovascular devices or interventional neurology market.
Get Sample Report Enquiry Before Buying